Literature DB >> 23748835

Bilateral pneumothorax complicating cystic metastases of bronchial squamous cell carcinoma under erlotinib.

Etienne Giroux Leprieur1, Coraline Dumenil, Sylvie Labrune, Violaine Giraud, Thierry Chinet.   

Abstract

Cystic lung metastases are a rare presentation in non-small cell lung cancer and occurs mainly in squamous cell carcinoma. We present the case of a 57-year-old woman with a lung squamous cell carcinoma and cystic lung metastases, who developed bilateral metachronous pneumothorax while being administered erlotinib in third-line treatment. The apparition of a pneumothorax under chemotherapy is most often the result of tumor necrosis and formation of bronchopleural fistula. However, very few cases have been reported under targeted therapies, and to our knowledge this is the first case under erlotinib. This complication is potentially life-threatening, especially due to the possibility of pneumothorax bilateralization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23748835     DOI: 10.1177/030089161309900234

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

Review 1.  Spontaneous pneumothorax in diffuse cystic lung diseases.

Authors:  Joseph Cooley; Yun Chor Gary Lee; Nishant Gupta
Journal:  Curr Opin Pulm Med       Date:  2017-07       Impact factor: 3.155

2.  A rare complication of metastatic lung disease treatment.

Authors:  Burcin Celik; Muzaffer Elmali; Okan Gulel; Mustafa K Demirag
Journal:  Saudi Med J       Date:  2017-12       Impact factor: 1.484

3.  Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots.

Authors:  Fumio Imamura; Norio Okamoto; Takako Inoue; Junji Uchida; Kazumi Nishino; Madoka Kimura; Toru Kumagai; Jiro Okami
Journal:  Respir Med Case Rep       Date:  2015-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.